- U.S. News & World Report Survey: Health Experts Rank Core Lifestyle Habits Ahead of Biohacks for Longevity
- Four NHL Teams With Too Many Players On Trade And Movement Clauses
- ‘Landman’ star Michelle Randolph rocks white bikini months after going Instagram official with Glen Powell
- Lionel Richie hospitalized in St Louis after summer of health scares and canceled concerts
- First Quantum
- Trump says Iran is ‘DEAD’ — experts point to the real sign Tehran is nearing the brink
- Rutland homeowner cuts down trees over concerns about homeless activity
- Labor Department has good news for American workers
Business & Finance
Health insurance costs have been punishing self-employed workers and small business owners all year. Affordable Care Act (ACA) marketplace premiums have climbed sharply as federal subsidies expired, and millions of freelancers, gig workers, and sole proprietors have been absorbing the full hit with no relief in sight
U.S. Treasury Secretary Scott Bessent reportedly told Russian Finance Minister Anton Siluanov that no sanctions relief or new agreements with Moscow were possible, as long as the war in Ukraine continues
US stocks declined on Monday after the US attacked Iran for the first time in weeks, fueling a rise in oil prices and increased bets that the Federal Reserve would raise interest rates at its September meeting
Wall Street can usually agree on a stock to within a few percentage points. On memory maker Sandisk (NASDAQ: SNDK), it can’t come within $1,430 — at least that is the case for two analysts
More Americans admitted to shoplifting in the past year, with most saying they were not caught
A warm “howdy” to our western neighbors from Midland for challenging the state in court over its outdated public education finance system
The stock market has spent much of 2026 rewriting the record books. Artificial intelligence spending continues to climb, hyperscalers are expected to commit over $1 trillion to new data centers next year, electricity demand is reaching levels utilities have never planned for, and IPO valuations have returned to nosebleed territory. Even Washington is setting records,…
Pfizer (NYSE: PFE) has a shockingly high dividend yield of 6.8%. The S&P 500 Index (SNPINDEX: ^GSPC) has a 1% yield, and the average pharmaceutical stock’s yield is roughly 1.5%. Given that huge disparity, it looks like Pfizer’s yield is too good to be true
As we reach the mid-point of the year, we need to face the unpleasant history of mid-term election years as the worst year of the four in a four-year investment cycle